Drug Topics

MARCH 16, 2023

The combination of prednisone and methotrexate provided nearly complete or complete hair regrowth in up to 31.2% of patients with alopecia areata.

247

247

STAT

MARCH 16, 2023

Experts have long understood that a new polio vaccine developed to try to minimize the risks associated with the oral polio vaccine made by Albert Sabin might also cause the problem it was created to sidestep. It’s now clear that theoretical risk is a real one. The Global Polio Eradication Initiative announced Thursday that six children in the Democratic Republic of the Congo and one in Burundi have been paralyzed by viruses from the new vaccine, which is referred to as novel oral polio v

Vaccines 143

Vaccines 143

Drug Topics

MARCH 16, 2023

Treating myelofibrosis with Jakafi earlier has shown promise in improving both survival and symptom burden

247

247

PharmaVoice

MARCH 16, 2023

The recent departure of neurodegenerative development head Samantha Budd Haeberlein is just the latest sign of a changing tide among Biogen’s post-Aduhelm leadership.

130

130

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

Fierce Healthcare

MARCH 16, 2023

Pennsylvania systems Penn Medicine, Crozer Health cut jobs amid reorganizations dmuoio Thu, 03/16/2023 - 16:19

120

120

PharmaVoice

MARCH 16, 2023

A $43 billion deal that doubles the pharma giant's cancer pipeline shows that M&A is back on the table in pharma.

130

130

Fierce Pharma

MARCH 16, 2023

AstraZeneca employees fight layoffs in India as drugmaker shifts 'strategic priorities' aliu Thu, 03/16/2023 - 09:54

106

106

Pharmaceutical Technology

MARCH 16, 2023

Talem Therapeutics, a subsidiary of Immunoprecise Antibodies, has entered a multi-target artificial intelligence (AI)-driven antibody discovery collaboration with Libera Bio. The partnership will use nanotechnology, which was proven in vivo, for providing antibodies inside tumour cells and provides a potential solution to address the medical challenge.

Compounding 104

Compounding 104

Fierce Pharma

MARCH 16, 2023

Moderna, riding COVID success and busy growing its pipeline, hikes pay of CEO Bancel to $19.

103

103

STAT

MARCH 16, 2023

Are you six months out from your Covid-19 bivalent booster and wondering when you’ll be able to get another shot? If you live in the United Kingdom or Canada, you already have your answer. The Canadian and U.K. governments, acting on recommendations from expert committees, plan to offer spring booster shots for people at highest risk of getting severely sick from Covid.

FDA 103

FDA 103

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Fierce Pharma

MARCH 16, 2023

Novo Nordisk hit with two-year suspension from UK pharma group after online marketing breaches fkansteiner Thu, 03/16/2023 - 09:00

100

100

STAT

MARCH 16, 2023

One of the largest operators of ketamine clinics in the country abruptly closed its facilities this week, leaving patients in the dark and out of treatment for depression and other chronic conditions. Ketamine Wellness Centers spanning nine states were shuttered, leaving laid-off employees and patients with more questions than answers. Interest in ketamine to treat depression and other conditions has grown in recent years.

101

101

DiversifyRx

MARCH 16, 2023

Let’s talk about all things staff meetings We don’t have a choice. Running staff meetings is a necessity we can not ignore if we want to create a badass pharmacy team. Staff meetings are an opportunity to gain more team engagement, discuss new and upcoming initiatives, collaborate on ideas, learn what’s working and what’s not, and uncover any customer service issues that need attention.

Customer Service 98

Customer Service Independent Pharmacies Documentation Communication 98

STAT

MARCH 16, 2023

In a rare move, a U.K. pharmaceutical industry trade group suspended Novo Nordisk for two years due to “serious breaches” involving the promotion of a weight-loss drug that violated a code of practice and discredited the entire sector. The Association of the British Pharmaceutical Industry took this step after receiving a complaint alleging the company had sponsored courses on weight management on LinkedIn for health professionals, without making clear that it was involved in the s

101

101

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Drug Store News

MARCH 16, 2023

Fine’ry, available exclusively at Target, is inspired by perfume icons in the industry and features a diverse range of fragrances that offer unique scent experiences.

98

98

STAT

MARCH 16, 2023

WASHINGTON — FDA Commissioner Robert Califf wants private insurers to chip in on doing post-approval clinical research on drugs. It’s a new request from the agency chief, who’s long pushed to find new ways to test drugs. “I’m not aware of a major effort by the insurance plans to help people get studies done,” he said at America’s Health Insurance Plans conference on Thursday.

Insurance 100

Insurance FDA 100

ISPE

MARCH 16, 2023

New Trends & Requirements from Digitalization, Annex 1, Continuous Manufacturing & High Potent Manufacturing Trudy Patterson Thu, 03/16/2023 - 08:00 iSpeak Blog iSpeak New Trends & Requirements from Digitalization, Annex 1, Continuous Manufacturing & High Potent Manufacturing Natalia Nikolaevna Vtyurina, PhD Dany SHAMI Richard Denk Amjad Wahbeh 16 March 2023 The pharmaceutical industry is rapidly evolving.

Pharmaceutical Companies 98

Pharmaceutical Companies Pharmaceutical Companies Documentation Compounding 98

STAT

MARCH 16, 2023

In a sudden about-face, the Food and Drug Administration will hold a meeting of outside experts to consider whether or not to approve Sarepta’s experimental gene therapy for Duchenne muscular dystrophy. The announcement Thursday comes just weeks after the company said the FDA had told it an advisory panel meeting to review the treatment, called SRP-9001, would not be necessary.

FDA 100

FDA 100

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Drug Store News

MARCH 16, 2023

Funds were raised through a Round Up at the Register campaign in honor of Black History Month.

98

98

STAT

MARCH 16, 2023

U.S. regulators approved dozens of inhalers to treat asthma and chronic obstructive pulmonary disease over a recent 15-year period, but a new study found that generic companies have only twice successfully pursued an established pathway to create lower-cost, rival products. The paltry outcome was largely blamed on steps that brand-name manufacturers take to forestall would-be competitors, as well as the high bar for regulatory approval.

100

100

Drug Store News

MARCH 16, 2023

DSN's editor-in-chief shares how retail pharmacies can provide health care access to people and communities who need it the most.

98

98

STAT

MARCH 16, 2023

Following the lead of its rivals, Sanofi will cut the price of its most widely prescribed insulin in the U.S. by 78% and also place a $35 cap on out-of-pocket costs for commercially insured patients who take the treatment, which is called Lantus. The moves will go into effect on Jan. 1, 2024. The change comes after Eli Lilly and then Novo Nordisk announced plans this month to reduce list prices for some of their own insulin products by similar amounts.

Insurance 98

Insurance 98

Fierce Healthcare

MARCH 16, 2023

Cerebral shared private health data on 3.

98

98

STAT

MARCH 16, 2023

Before there was CRISPR, aspiring genome editors relied on an island of misfit, less elegantly named enzymes: Zinc-finger nucleases, TALENs, recombinases. Many of these once beloved tools were tossed aside when CRISPR came along, having helped few actual patients but driven plenty of graduate students to exhaustion. They were stubborn, inflexible enzymes, requiring endless engineering.

98

98

Fierce Healthcare

MARCH 16, 2023

FDA's Califf calls on insurers to help providers participate in critical clinical drug trials rking Thu, 03/16/2023 - 11:55

Insurance 98

Insurance FDA 98

STAT

MARCH 16, 2023

It’s the gold standard in medicine: taking a treatment, and putting it head-to-head against a placebo to confidently declare whether it actually works. But for most medical devices, placebo trials have never been done. The most basic argument for this, put forth by medical device makers and regulators, is that mimicking an invasive procedure is far more difficult than handing patients a sugar pill.

FDA 98

FDA 98

Fierce Healthcare

MARCH 16, 2023

True catastrophic coverage and shifting liability: Preparing for IRA changes mteefey Thu, 03/16/2023 - 15:34

98

98

Drug Store News

MARCH 16, 2023

Available in hickory barbecue and sour cream and onion flavors, each portion-controlled serving contains 12 g of protein, the company said.

98

98

STAT

MARCH 16, 2023

Is AI dictating patient care? What happens when your bank falls apart? And can Illumina endure some shareholder activism? We cover all that and more this week on the 250th episode of “The Readout LOUD,” STAT’s biotech podcast. STAT reporter Bob Herman joins us to explain how treatment algorithms powered by artificial intelligence are being used more frequently by Medicare Advantage plans to deny claims, even when continued treatment is medically justified.

Patient Care 98

Patient Care 98

European Pharmaceutical Review

MARCH 16, 2023

The combination modulator therapy tezacaftor (TEZ) and ivacaftor (IVA) for cystic fibrosis (CF) has demonstrated long-term safety and clinical benefit in a four-year trial. The two CF modulators were assessed in patients 12 years and older. The participants tolerated the combination regimen over the course of the 96-week extension study. These patients had previously participated in a 120-day trial of the same combination.

Hospitals 98

Hospitals 98

Hospital Pharmacy Europe

MARCH 16, 2023

Trofinetide is approved for treatment of the rare, neuro-developmental disorder Rett Syndrome in patients from two years of age Acadia Pharmaceuticals announced that the company has been given approval by the FDA for trofinetide to be used as a treatment for adult and paediatric patients with Rett Syndrome from two years of age. Rett syndrome is described as a neuro-developmental disorder characterised by typical early growth and development followed by a slowing of that development, loss of fun

FDA 98

FDA Hospitals 98

Drug Store News

MARCH 16, 2023

Dollar General's Q4 net sales increased by 17.9%, and fiscal year net sales increased by 10.6%.

98

98

European Pharmaceutical Review

MARCH 16, 2023

Stem cells from cord blood have potentially cured the first mixed race female patient of HIV, scientists say. Using these stem cells rather than from compatible adult donors, as has been done previously, increases the potential to cure HIV via stem cell transplantation in people of all racial backgrounds.” The patient, who had leukaemia and HIV has been without HIV since 2017, because of a new method, transplanting HIV-resistant stem cells from umbilical cord blood.

97

97